Skip to main content
. 2017 Dec 31;50(12):615–620. doi: 10.5483/BMBRep.2017.50.12.096

Fig. 1.

Fig. 1

FN expression is associated with poor prognosis in patients with luminal type A breast cancer. (A) Relapse-free survival. FN expression data were obtained from a public database (http://kmplot.com/breast). The clinical value of FN was analyzed by generating a Kaplan-Meier survival plot for patients with luminal A and B type breast cancer. (B) The levels of FN mRNA and protein expression were analyzed by real-time PCR and Western blotting, respectively. Results are representative of three independent experiments. Data are presented as means ± SEMs. *P < 0.01 vs. TamS cells.